孕酮在延长实验性大鼠原位胶质母细胞瘤同种移植模型总生存期及保留神经功能方面比地塞米松更有效
该研究在大鼠原位C6胶质母细胞瘤模型中比较地塞米松1 mg/kg、孕酮10 mg/kg和孕酮20 mg/kg连续给药5天的效果。孕酮10 mg组总生存期显著更长,神经功能和体重保留更好,血脑屏障通透性优于地塞米松组,可能与下调基质金属蛋白酶-9和水通道蛋白-4有关,孕酮组还观察到抗血管生成反应。作者认为孕酮可作为减少皮质类固醇使用的药物,但需进一步转化和临床研究。
要点
- 孕酮10 mg/kg组总生存期显著长于地塞米松1 mg/kg组,神经功能和体重保留更好。
- 孕酮10 mg/kg组血脑屏障通透性优于地塞米松组,可能与下调基质金属蛋白酶-9和水通道蛋白-4有关。
- 孕酮组观察到抗血管生成反应。
核心结论
- 该概念验证性初步研究提供新信息:孕酮可作为脑肿瘤管理中减少皮质类固醇使用的药物。
- 作者认为需进一步转化和临床研究。
研究设计与样本
- 研究使用雄性Sprague-Dawley大鼠原位C6胶质母细胞瘤模型,肿瘤移植后生长14天再给予药物处理。
- 药物处理分组为地塞米松1 mg/kg、孕酮10 mg/kg或孕酮20 mg/kg,连续给药5天。
- 评估动物总生存期和神经功能,并在离体肿瘤移植物上进行血脑屏障通透性和血管生成反应机制研究。
主要发现
- 所有药物处理均不同程度延长总生存期。
- 孕酮10 mg/kg组总生存期显著更长,神经功能和体重保留更好。
- 孕酮10 mg/kg组血脑屏障通透性比地塞米松组保留更好,可能通过下调基质金属蛋白酶-9和水通道蛋白-4表达实现。
- 孕酮组观察到抗血管生成反应。
临床怎么用
- 作者认为孕酮可作为脑肿瘤管理中减少皮质类固醇使用的药物。
- 作者认为需进一步转化和临床研究。
局限性
- 该研究为概念验证性初步研究,需进一步转化和临床研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Dexamethasone (DEXA) has been widely used in the management of peritumoral brain edema. DEXA, however, has many systemic side effects and can interact negatively with glioma therapy. Progesterone (PROG), however, is a well-tolerated and readily accessible anti-inflammatory and antiedema agent, with potent neuroprotective properties. We investigated whether PROG could serve as a viable alternative to DEXA in the management of peritumoral brain edema. METHODS: We used an orthotopic C6 glioblastoma model with male Sprague-Dawley rats. Tumor grafts were allowed to grow for 14 days before drug treatment with DEXA 1 mg/kg, PROG 10 mg/kg, or PROG 20 mg/kg for 5 consecutive days. The overall animal survival and neurologic function were evaluated. Mechanistic studies on blood-brain barrier permeability and angiogenic responses were performed on the ex vivo tumor grafts. RESULTS: We found that all drug treatments prolonged overall survival to different extents. PROG 10 mg led to significantly longer survival and better preservation of neurologic function and body weight. The blood-brain barrier permeability was better preserved with PROG 10 mg than with DEXA, possibly through downregulation of matrix metalloproteinase-9 and aquaporin-4 expression. Antiangiogenic responses were also observed in the PROG group. CONCLUSIONS: The present proof-of-concept pilot study has provided novel information on the use of PROG as a corticosteroid-sparing agent in brain tumor management. Further translational and clinical studies are warranted.
引用
- Cheng Y, Yeung WL, Zhang P, et al. Progesterone Is More Effective Than Dexamethasone in Prolonging Overall Survival and Preserving Neurologic Function in Experimental Animals with Orthotopic Glioblastoma Allografts. World Neurosurg. 2019. PMID: 30710720. doi:10.1016/j.wneu.2019.01.113
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。